The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
Abstract
PURPOSE: We observed that quality-of-life (QL) scores, collected to evaluate treatment in a randomized trial in advanced breast cancer, predicted survival duration. This report explores the prognostic associations between QL and survival in more detail. PATIENTS AND METHODS: In a randomized clinical trial comparing intermittent and continuous therapy policies for patients with advanced breast cancer, QL was measured by linear analog self-assessment (LASA) and the Quality-of-Life Index (QLI). Baseline scores and subsequent changes were included in statistical models of survival duration, with and without other prognostic factors. RESULTS: Physician assessment of QLI and patient LASA scores for physical well-being (PWB), mood, nausea and vomiting, appetite, and overall QL (but not pain) at the commencement of treatment were significant predictors of subsequent survival. Scores for PWB and QLI were independent of other prognostic factors. Changes in scores were also prognostically important. Both baseline and change in scores for PWB, mood, pain, and QLI after the first three treatment cycles, but before an arbitrary 180-day time point, were significantly predictive of survival beyond that time. Both QLI and PWB were prognostically independent of tumor response. Although QL improvement was correlated with tumor response, continuous therapy yielded significantly better QL scores, even in nonresponders. CONCLUSION: These findings support the validity of the simple QL measures used in the trial. They are compatible with the simple explanation that patients perceive disease progression before it is clinically evident, but also with a causal relationship between QL and survival duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the quality of life of cancer patients
Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., Battista, R. N., & Catchlove, B. R. (1981) · Journal of Chronic Diseases · doi:10.1016/0021-9681(81)90058-8 · Cited by 1,528
An Extension of Shapiro and Wilk's W Test for Normality to Large Samples
Royston, J. P. (1982) · Applied Statistics · doi:10.2307/2347973 · Cited by 1,399
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
Coates, A., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Snyder, R., Tattersall, M. H. N., Byrne, M., Harvey, V., Gill, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172402 · Cited by 537
Self-citationTannock, I. F., Boyd, N. F., DeBoer, G., Erlichman, C., Fine, S., Larocque, G., Mayers, C., Perrault, D., & Sutherland, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1377 · Cited by 348
Psychological response to breast cancer and 15-year outcome
GREER, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90173-3 · Cited by 253
Efficient Screening of Nonnormal Regression Models
Lawless, J. F., & Singhal, K. (1978) · Biometrics · doi:10.2307/2530022 · Cited by 235
Coates, A. S., Dillenbeck, C. F., McNeil, D., Kaye, S. B., Sims, K., Fox, R. M., Woods, R. L., Milton, G. W., Solomon, J., & Tattersall, M. H. N. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90096-2 · Cited by 156
Self-citationCan the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?
Addington-Hall, J., Macdonald, L., & Anderson, H. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.360 · Cited by 117
On the receiving end — III Measurement of quality of life during cancer chemotherapy
Coates, A. S., Glasziou, P., & McNeil, D. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057724 · Cited by 79
Self-citation
Cited by
Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C. M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,580
Montazeri, A. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-32 · Cited by 770
Maltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., Glare, P., Nabal, M., Viganò, A., Larkin, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.866 · Cited by 664
The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3439 · Cited by 644
Montazeri, A. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-102 · Cited by 568
Metadata
- Authors
- Coates, A., Gebski, V, Signorini, D., Murray, P., McNeil, D., Byrne, M., & Forbes, J. F.
- Venue
- Journal of Clinical Oncology
- Published
- 1992-12
- Volume
- 10
- Issue
- 12
- Pages
- 1833-1838
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1955223035
- Cited by
- 313
- References
- 14
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. https://app.cochat.ai/papers/10.1200/jco.1992.10.12.1833
- The paper
- Coates, A., Gebski, V, Signorini, D., Murray, P., McNeil, D., Byrne, M., & Forbes, J. F. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1992.10.12.1833
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.